Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • caddymob
    Member
    • Apr 2009
    • 36

    3' Adapter Trimming

    Hi everyone,

    I am using Maq for alignments and have found the 3' adapter trimming to be very informative about my overall run/sample prep quality. However, I am not clear about how this actually is working and have a couple questions...

    For instance, I have in one lane 13,145,392 quality filtered reads. Using the adapter trimming option I get 10,270,661 possible reads with adapter contamination, and a total of 2,949,120 paired reads mapping (3,404,692 total mapped). So this mapping number is greater than the number of reads NOT containing adapters 13,145,392-10,270,661 = 2,874,731.

    So, does Maq simply trim off any adapter and continue with alignment if the read is of sufficient length? Am I reading this correctly?

    Next, I have aligned the same exact reads to 3 different regions and for each I get 3 different counts for possible adapter contamination with everything else being equal. For the lane I mentioned above, I get a) 10,270,661 b) 10,473,317 and c) 10,299,171 counts for adapters but again these are the exact same reads, just a different region for alignment -- not huge differences, but differences nonetheless

    I whipped together a super simple perl script to count 3' adapters in my FASTQs and get nowhere near the same number..

    Code:
    $adapt = GATCGGAA;
    $count = 0;
    
    while (<>) {
      $line = $_;
      chomp $line;
      if ($line =~ m/^$adapt/) {
        $count++;
      }
    }
    print "\nThere are $count sequences with adapter!\n\n";
    Again, super simple, but with this for the aforementioned lane I get 6,615,038 reads containing adapter....

    Does anybody have some insight to any of these issues? Thanks everyone!

Latest Articles

Collapse

  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 12:17 PM
0 responses
11 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
11 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
23 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
37 views
0 reactions
Last Post SEQadmin2  
Working...